We are thrilled about our participation at the Pharmabiotics Conference & Partnering 2024. The event took place in Lille, France, marking the 9th edition of this prestigious conference.
As a member of the Board of Directors of the Pharmabiotic Research Institute (PRI), Accelsiors played a crucial role in fostering collaboration and knowledge sharing within the pharmaceutical research community. With Jelena Helene Cvejic, Director of Translational Science, leading the way, Accelsiors remains well-positioned to contribute valuable insights.
Our presence at the conference symbolizes our commitment to driving innovation and improving human health on a global scale. We are honored that our leadership role within PRI further solidifies our dedication to staying at the forefront of the industry.
The theme of this year’s conference, “An Evolving Regulatory Landscape,” highlighted the dynamic changes occurring in the regulatory environment. At Accelsiors, we recognize the importance of staying abreast of these changes and we’re eager to engage in discussions surrounding the most innovative approaches in microbiome-specialized drug development.
The conference provided an exceptional platform for Accelsiors to gain valuable insights, learn about cutting-edge tools and resources, and plan for successful clinical trials in the microbiome health field. We extend our gratitude to the organizers, presenters, and panelists for sharing their expertise and contributing to the advancement of the industry.
As pioneers in the field, Accelsiors is already preparing for the next edition of the conference. We invite industry professionals and enthusiasts alike to join us in driving innovation, forging meaningful partnerships, and ultimately making a positive impact on human health worldwide.
